Lung Cancer

In 2020, lung cancer ranked second with a global incidence of 22,06,771 diagnoses, accounting for 11.4% of all cancers, and mortality with 17,96,144 deaths, accounting for 18% [1]. The 5-year survival rate for men and women is 17% and 24%, respectively. According to GLOBOCAN, the incidence is highest in Eastern Asia (10,12,021 cases), followed by Central and Eastern Europe (1,51,632 cases), and Western Europe (1,46,460 cases). Similarly, mortality is highest in Eastern Asia (8,41,174 deaths), followed by North America (1,59,641 deaths), and Central and Eastern Europe (1,30,596 deaths). The global incidence is significantly higher in males (14,35,943 cases, cumulative risk of 3.78) than in females (7,70,828 cases, cumulative risk 1.77). Similarly, global mortality rates are also higher in males (11,88,679 deaths, cumulative risk 3.08) than in females (607,465 deaths, cumulative risk 1.34). As per the SEER data in the United States, the median age of diagnosis and death is 71 and 72 years, respectively.